Cubist Systematic Strategies’s Cue Biopharma CUE Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-3,661
| Closed | -$3.99K | – | 1625 |
|
2024
Q4 | $3.99K | Buy |
+3,661
| New | +$3.99K | ﹤0.01% | 1410 |
|
2024
Q3 | – | Sell |
-4,148
| Closed | -$5.14K | – | 1621 |
|
2024
Q2 | $5.14K | Buy |
+4,148
| New | +$5.14K | ﹤0.01% | 1338 |
|
2023
Q2 | – | Sell |
-40,320
| Closed | -$144K | – | 2419 |
|
2023
Q1 | $144K | Sell |
40,320
-67
| -0.2% | -$239 | ﹤0.01% | 2330 |
|
2022
Q4 | $115K | Hold |
40,387
| – | – | ﹤0.01% | 2818 |
|
2022
Q3 | $90K | Sell |
40,387
-21,776
| -35% | -$48.5K | ﹤0.01% | 3244 |
|
2022
Q2 | $155K | Buy |
62,163
+35,530
| +133% | +$88.6K | ﹤0.01% | 3263 |
|
2022
Q1 | $130K | Buy |
+26,633
| New | +$130K | ﹤0.01% | 3145 |
|
2021
Q4 | – | Sell |
-13,216
| Closed | -$193K | – | 3489 |
|
2021
Q3 | $193K | Sell |
13,216
-12,918
| -49% | -$189K | ﹤0.01% | 2596 |
|
2021
Q2 | $304K | Buy |
+26,134
| New | +$304K | ﹤0.01% | 2320 |
|
2021
Q1 | – | Sell |
-11,718
| Closed | -$147K | – | 2851 |
|
2020
Q4 | $147K | Buy |
+11,718
| New | +$147K | ﹤0.01% | 2343 |
|
2020
Q3 | – | Sell |
-21,723
| Closed | -$532K | – | 2511 |
|
2020
Q2 | $532K | Buy |
+21,723
| New | +$532K | 0.01% | 1559 |
|